Login to Your Account

Other News To Note

Friday, June 8, 2012
• Foundation Medicine Inc., of Cambridge, Mass., said it signed a deal with Novartis AG, of Basel, Switzerland, to provide comprehensive genomic analysis in support of Novartis' clinical oncology programs. Financial terms were not disclosed.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription